SR-2555
SR-2555 (NSC 314055) is a CYP2D6 inhibitor with an IC50 of 1017 μM against human CYP2D6. SR-2555 inhibits the AMMC demethylase activity of recombinant CYP2D6; differentially enhances the sensitivity of hypoxic cells to the lethal effect of γ-rays; and exhibits cytotoxicity against hypoxic cells. SR-2555 can be used in cancer-related research.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 74141-74-5
- Formel: C9H14N4O5
- Molecular Weight:258.23
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
|
CYP2D6 1017 μM (IC50) |
SR-2555 (NSC 314055) weakly inhibits recombinant CYP2D6-mediated AMMC demethylase activity, with an IC50 of 1017 μM[1].
SR-2555 exhibits radiosensitizing efficacy comparable to that of Misonidazole (HY-105061) in hypoxic Chinese hamster V79 cells[2].
SR-2555 (2-5 mM; up to 8 hours) exhibits the lowest cytotoxicity among the tested 2-nitroimidazole compoundstoward hypoxic Chinese hamster V79 cells[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS. Nr. 74141-74-5
-
Molecular Weight 258.23
-
Formel C9H14N4O5
-
SMILES
O=C(N(CCO)CCO)CN1C=CN=C1[N+]([O-])=O
-
Synonyms
NSC 314055
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)